Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EP300 | Q09472 | 1/20 | 0.55 |
| ▸ | FAAH | O00519 | 4/20 | 0.53 |
| ▸ | SOAT1 | P35610 | 2/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.53 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | TP53 | P04637 | 1/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.48 |
| ▸ | CNR1 | P21554 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | TERT | O14746 | 3/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | BLM | P54132 | 2/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.44 |
| ▸ | FABP4 | P15090 | 2/20 | 0.44 |
| ▸ | GMNN | O75496 | 1/20 | 0.44 |
| ▸ | USP2 | O75604 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19980211 | 0.91 | EP300 (0.43) | EP300FAAHSOAT1CYP1A2CYP2C19 | |
| SCHEMBL29134998 | 0.91 | EP300 (0.43) | EP300FAAHSOAT1CYP1A2CYP2C19 | |
| SCHEMBL27721505 | 0.85 | EP300 (0.64) | EP300FAAHSOAT1CYP1A2CYP2C19 | |
| SCHEMBL27822155 | 0.85 | EP300 (0.64) | EP300FAAHSOAT1CYP1A2CYP2C19 | |
| SCHEMBL1886380 | 0.85 | EP300 (0.64) | EP300FAAHSOAT1CYP1A2CYP2C19 | |
| SCHEMBL27841412 | 0.85 | EP300 (0.64) | EP300FAAHSOAT1CYP1A2CYP2C19 | |
| SCHEMBL6668610 | 0.85 | EP300 (0.64) | EP300FAAHSOAT1CYP1A2CYP2C19 | |
| SCHEMBL29702823 | 0.85 | EP300 (0.64) | EP300FAAHSOAT1CYP1A2CYP2C19 | |
| SCHEMBL27357142 | 0.85 | EP300 (0.64) | EP300FAAHSOAT1CYP1A2CYP2C19 | |
| SCHEMBL6669081 | 0.85 | EP300 (0.64) | EP300FAAHSOAT1CYP1A2CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 73 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260028671-A1 | Sequencing by Structure Assembly | HARVARD COLLEGE (US) | 2026-01-29 | — | — | US | disclosed |
| US-20250369043-A1 | LINKERS AND METHODS FOR OPTICAL DETECTION AND SEQUENCING | ULTIMA GENOMICS INC (US) | 2025-12-04 | — | — | US | disclosed |
| EP-4655423-A1 | INFERRING MICROORGANISM OF ORIGIN FOR ANTIMICROBIAL RESISTANCE MARKERS IN TARGETED METAGENOMICS | Illumina, Inc. (US) | 2025-12-03 | — | — | EP | disclosed |
| US-12467086-B2 | Sequencing by structure assembly | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2025-11-11 | — | — | US | disclosed |
| US-20250277224-A1 | COMPOSITIONS AND METHODS FOR PRODUCING CIRCULAR POLYRIBONUCLEOTIDES | FLAGSHIP PIONEERING INNOVATIONS VI, LLC | 2025-09-04 | — | — | US | disclosed |
| US-12378600-B2 | Linkers and methods for optical detection and sequencing | ULTIMA GENOMICS, INC. (US) | 2025-08-05 | — | — | US | disclosed |
| US-12338474-B2 | Compositions and methods for producing circular polyribonucleotides | FLAGSHIP PIONEERING INNOVATIONS VI, LLC (US) | 2025-06-24 | — | — | US | disclosed |
| US-20250188505-A1 | PRODUCTION OF CIRCULAR POLYRIBONUCLEOTIDES IN A PROKARYOTIC SYSTEM | FLAGSHIP PIONEERING INNOVATIONS VII LLC (US) | 2025-06-12 | — | — | US | disclosed |
| WO-2025097012-A1 | METHODS OF SORTING SPERM BASED ON GENOTYPE | MAVEN BONNIE E J (US) | 2025-05-08 | — | — | WO | disclosed |
| US-20250129419-A1 | REAGENTS FOR LABELING BIOMOLECULES AND USES THEREOF | ULTIMA GENOMICS INC (US) | 2025-04-24 | — | — | US | disclosed |
| CN-114007614-A | Methods and compositions for modulating splicing | 斯基霍克疗法公司 | 2022-02-01 | — | — | CN | disclosed |
| CN-114007613-A | Methods and compositions for modulating splicing | 斯基霍克疗法公司 | 2022-02-01 | — | — | CN | disclosed |
| CN-114007612-A | Methods and compositions for modulating splicing | 斯基霍克疗法公司 | 2022-02-01 | — | — | CN | disclosed |
| CN-114007611-A | Methods and compositions for modulating splicing | 斯基霍克疗法公司 | 2022-02-01 | — | — | CN | disclosed |
| US-20180340020-A1 | PEPTIDE-MEDIATED DELIVERY OF IMMUNOGLOBULINS ACROSS THE BLOOD-BRAIN BARRIER | MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH | 2018-11-29 | — | — | US | disclosed |
| US-10072065-B2 | Peptide-mediated delivery of immunoglobulins across the blood-brain barrier | MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) | 2018-09-11 | — | — | US | disclosed |
| US-20170058017-A1 | PEPTIDE-MEDIATED DELIVERY OF IMMUNOGLOBULINS ACROSS THE BLOOD-BRAIN BARRIER | MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH | 2017-03-02 | — | — | US | disclosed |
| US-8715923-B2 | Protein scaffolds and viral particles for detecting analytes | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 2014-05-06 | — | — | US | disclosed |
| US-20080220408-A1 | Non-enveloped virus particles comprising a plurality of detectable fluorescent labels for use in solid support for detecting preferential particles in solutions | THE GOVERNMENT OF THE US, AS REPRESENTED BY THE SE (US) | 2008-09-11 | — | — | US | disclosed |
| WO-2006124044-A2 | PROTEIN SCAFFOLDS AND VIRAL PARTICLES FOR DETECTING ANALYTES | GEORGE MASON UNIVERSITY (US) | 2006-11-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260028671-A1 | Sequencing by Structure Assembly | POLL, CPSF7, POLM | EP300 4879/4885FAAH 1883/4885SOAT1 3802/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.